Status:
RECRUITING
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Lead Sponsor:
University of Colorado, Denver
Conditions:
Hemorrhage
Eligibility:
FEMALE
18-55 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.
Eligibility Criteria
Inclusion
- clinic-based D\&E at 18 weeks gestational age and above
- speaks English or Spanish
Exclusion
- refuses IV
- history of coagulopathy
- anticoagulant use in the preceding five days
- chorioamnionitis or sepsis
- suspected placenta accreta spectrum
- intrauterine fetal demise
- multiple gestation
- use of misoprostol for cervical preparation
Key Trial Info
Start Date :
May 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 2 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06141447
Start Date
May 2 2024
End Date
November 2 2026
Last Update
December 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Women's Health Center
Denver, Colorado, United States, 80230